Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Does Minoxidil Cause Hyperpigmentation? Hair and Skin Effects

By
Published Updated Last reviewed
9 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Main skin effect / unwanted hair growth (hypertrichosis) [1]
  • Pigment change described / enhanced pigmentation of fine body hair, part of hypertrichosis [1]
  • Rate at antihypertensive doses / about 80% [1]
  • Rate at low doses / 15.1% in 1,404 patients [2]
  • Onset / 3 to 6 weeks at antihypertensive doses [1]
  • After stopping / new hair growth stops; 1 to 6 months to pretreatment appearance [1]
  • FDA status / oral tablets approved only for severe hypertension; hair loss use not approved [1]
  • Blood pressure at low dose / no significant change at 5 mg/day or less; heart rate +2.67 beats/min [3]

Does Minoxidil Cause Skin Hyperpigmentation?

The oral minoxidil label describes a specific dermatologic reaction: hypertrichosis, with elongation, thickening and enhanced pigmentation of fine body hair [1]. The label's adverse reactions section lists that reaction and rare rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, but not skin hyperpigmentation [1]. The hypertrichosis develops in about 80% of patients taking minoxidil tablets, begins within 3 to 6 weeks, and usually appears first at the temples, between the eyebrows and in the sideburn area before spreading to the back, arms, legs and scalp [1]. The topical 5% solution label mentions changes in hair color and/or texture and scalp irritation or redness [4].

What Does Enhanced Pigmentation Mean in the Label?

The label calls the effect hypertrichosis without virilism and says no endocrine abnormality has been found to explain it [1]. In the label's wording, the pigmentation belongs to the fine body hair itself: the hairs become longer, thicker and more pigmented [1]. When the drug is stopped, new hair growth stops, but 1 to 6 months may be needed for restoration to pretreatment appearance [1].

How Common Is Hypertrichosis at Low Doses?

The tablet label reports hypertrichosis in about 80% of patients taking minoxidil tablets, starting within 3 to 6 weeks [1]. A separate low-dose hair-loss cohort reported it in 15.1%: in a retrospective multicenter study of 1,404 patients (943 women, 461 men; mean age 43) treated with low-dose oral minoxidil for at least 3 months, 15.1% developed hypertrichosis, and 14 patients (0.5%) stopped treatment because of it [2]. That cohort had no control group, so its figure is not a controlled dose comparison with the label's rate at antihypertensive doses [1][2].

A 2025 meta-analysis of low-dose oral minoxidil at 5 mg/day or less found hypertrichosis was the most frequent side effect and accounted for 34.6% of discontinuations [3]. A 2022 meta-regression of six studies in androgenetic alopecia found each additional 1 mg/day was associated at 6 months with 47.1 more hairs/cm2, a 17.9% higher risk of hypertrichosis and a 4.8% higher risk of cardiovascular adverse events; the authors described these as associations, not causal evidence [5].

Does Low-Dose Oral Minoxidil Grow Hair?

Low-dose oral minoxidil for hair loss is off-label. The tablet label states that use of minoxidil tablets, in any formulation, to promote hair growth is not an approved indication [1]. The approved indication is hypertension that is symptomatic or associated with target organ damage and not manageable with maximum doses of a diuretic plus two other antihypertensive drugs [1].

A review of 17 studies with 634 patients concluded oral minoxidil appeared effective and well tolerated in healthy patients who had difficulty with topical formulations, and that larger randomized dose-comparison studies are needed [6]. One double-blind trial at a single clinic in Brazil randomized 90 men aged 18 to 55 with androgenetic alopecia to oral minoxidil 5 mg daily or topical minoxidil 5% twice daily for 24 weeks; 68 completed [7]. In that trial, the difference between oral and topical minoxidil in frontal and vertex terminal hair density was not statistically significant [7]. Another randomized trial of 65 patients found both oral minoxidil 1 mg/day and topical 5% improved hair diameter after 6 months (P<0.001), with no significant difference between groups [8]. For comparison, the tablet label's usual effective antihypertensive range is 10 to 40 mg/day [1].

What Else Happens at Hair-Loss Doses?

At 5 mg/day or less, a meta-analysis found systolic blood pressure changed by -0.13 mm Hg (95% CI -2.67 to 2.41) and diastolic by -1.25 mm Hg (-3.21 to 0.71). Heart rate rose by 2.67 beats/min (0.34 to 5.01). Hypotensive symptoms occurred in 119 patients (5.0%), with no hypotensive episodes [3].

In the 1,404-patient low-dose cohort, systemic effects were lightheadedness 1.7%, fluid retention 1.3%, tachycardia 0.9%, headache 0.4%, periorbital edema 0.3% and insomnia 0.2%; 29 patients (1.2%) stopped because of systemic effects, and no life-threatening adverse effects were observed [2].

The oral tablet label carries a boxed warning for pericardial effusion, occasionally progressing to tamponade, and for exacerbation of angina, and says minoxidil must usually be given with a beta blocker and a diuretic [1]. The label also warns about salt and water retention and congestive heart failure [1]. Those warnings are part of the tablet label, which is approved for severe hypertension [1].

Does Topical Minoxidil Cause the Same Effects?

Topical minoxidil is a separate over-the-counter product [9]. The men's 5% solution label covers the top of the scalp only and says it is not intended for frontal baldness or a receding hairline [4]. It warns that some people have experienced changes in hair color and/or texture [4]. Its listed skin-related warnings are scalp irritation or redness and unwanted facial hair growth [4].

Frequently asked questions

Does oral minoxidil cause skin hyperpigmentation?
The oral label does not list skin hyperpigmentation as an adverse reaction [1]. The pigmentation it describes belongs to the hair: fine body hair becomes longer, thicker and more pigmented as part of hypertrichosis [1].
What does minoxidil do to hair color?
The oral label describes elongation, thickening and enhanced pigmentation of fine body hair as part of hypertrichosis [1]. The topical 5% solution label warns that some people have experienced changes in hair color and/or texture [4].
How common is hypertrichosis with low-dose oral minoxidil?
In a 1,404-patient cohort treated for at least 3 months, 15.1% had hypertrichosis and 0.5% stopped treatment because of it [2]. In a meta-analysis of 5 mg/day or less, hypertrichosis was the most frequent side effect and accounted for 34.6% of discontinuations [3].
Does unwanted hair growth go away after stopping minoxidil?
The oral label says new hair growth stops after discontinuation, but 1 to 6 months may be needed for restoration to pretreatment appearance [1].
Does low-dose oral minoxidil lower blood pressure?
A meta-analysis of 5 mg/day or less found no significant change in systolic or diastolic blood pressure, but heart rate rose by 2.67 beats/min [3]. Hypotensive symptoms were reported in 5.0% of patients, with no hypotensive episodes [3].
Is oral minoxidil FDA-approved for hair loss?
No. The oral tablet label states that use to promote hair growth, in any formulation, is not an approved indication [1]. Oral minoxidil tablets are approved only for severe hypertension [1].

References

  1. U.S. National Library of Medicine, DailyMed. Minoxidil tablets (oral) prescribing information. Minoxidil tablets (oral) label
  2. Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
  3. Chen M, Weichert M, Guo W, Ruzic R, Briley J. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis. J Am Acad Dermatol. 2025;92(3):554-555. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis
  4. U.S. National Library of Medicine, DailyMed. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue prescribing information. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue label
  5. Gupta AK, Hall DC, Talukder M, Bamimore MA. There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses. Skin Appendage Disord. 2022;8(5):355-361. There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses
  6. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. Oral minoxidil treatment for hair loss: A review of efficacy and safety
  7. Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial
  8. Asilian A, Farmani A, Saber M. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol. 2024;23(3):949-957. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial
  9. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
Evidence overview for oral minoxidil: Does Minoxidil Cause Hyperpigmentation? Hair and Skin Effects